These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29730282)

  • 1. Incidence of radiographically occult nodal metastases in HPV+ oropharyngeal carcinoma: Implications for reducing elective nodal coverage.
    Loganadane G; Kelly JR; Lee NC; Kann BH; Mahajan A; Hansen JE; Belkacémi Y; Yarbrough W; Husain ZA
    Pract Radiat Oncol; 2018; 8(6):397-403. PubMed ID: 29730282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of contralateral-bilateral nodes in the human papillomavirus era.
    Tritter AG; Mehta V; Samuelson M; deGravelle G; Ma X; Medlin-Moore T; Takalkar A; Caldito G; Nathan CO
    Laryngoscope; 2017 Jun; 127(6):1328-1333. PubMed ID: 27905120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
    Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes.
    Han M; Lee SJ; Lee D; Kim SY; Choi JW
    Clin Radiol; 2018 Aug; 73(8):757.e21-757.e27. PubMed ID: 29779759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus-Associated Oropharyngeal Cancer: Patterns of Nodal Disease.
    Plonowska KA; Strohl MP; Wang SJ; Ha PK; George JR; Heaton CM; El-Sayed IH; Mallen-St Clair J; Ryan WR
    Otolaryngol Head Neck Surg; 2019 Mar; 160(3):502-509. PubMed ID: 30274544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.
    Lee NCJ; Kelly JR; Park HS; Yarbrough WG; Burtness BA; Husain ZA
    Pract Radiat Oncol; 2017; 7(5):e317-e321. PubMed ID: 28356201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal response after 46 Gy of intensity-modulated radiotherapy is associated with human papillomavirus-related oropharyngeal carcinoma.
    Dronkers EAC; Koljenovic S; Verduijn GM; Baatenburg de Jong RJ; Hardillo JAU
    Laryngoscope; 2018 Oct; 128(10):2333-2340. PubMed ID: 29521420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
    McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
    Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the risk of involvement for each neck nodal level in patients with early T-stage node-positive oropharyngeal carcinoma.
    Sanguineti G; Califano J; Stafford E; Fox J; Koch W; Tufano R; Sormani MP; Forastiere A
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1356-64. PubMed ID: 19131181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of Nodal Metastases and Predictors of Occult Disease in HPV-Associated Oropharynx Cancer.
    Stanford-Moore GB; Ochoa E; Larson A; Han M; Hoppe K; Ryan WR
    Otolaryngol Head Neck Surg; 2021 Mar; 164(3):624-630. PubMed ID: 32894979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.
    Patel MR; Hudgins PA; Beitler JJ; Magliocca KR; Griffith CC; Liu Y; Bougnon K; El-Deiry M; Saba NF; Aiken AH
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(2):85-95. PubMed ID: 29969771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the 8
    van Gysen K; Stevens M; Guo L; Jayamanne D; Veivers D; Wignall A; Pang L; Guminski A; Lee A; Hruby G; Macleod P; Taylor A; Eade T
    BMC Cancer; 2019 Jul; 19(1):674. PubMed ID: 31288767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Keane FK; Chen YH; Neville BA; Tishler RB; Schoenfeld JD; Catalano PJ; Margalit DN
    Cancer; 2015 Aug; 121(15):2594-602. PubMed ID: 25873094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid Lymph Nodes as an Imaging Biomarker for Risk Stratification in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Rath TJ; Narayanan S; Hughes MA; Ferris RL; Chiosea SI; Branstetter BF
    AJNR Am J Neuroradiol; 2017 Jul; 38(7):1405-1410. PubMed ID: 28450437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
    Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
    Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
    Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End of treatment cone-beam computed tomography (CBCT) is predictive of radiation response and overall survival in oropharyngeal squamous cell carcinoma.
    Sumner W; Kim SS; Vitzthum L; Moore K; Atwood T; Murphy J; Miyauchi S; Califano JA; Mell LK; Mundt AJ; Sharabi AB
    Radiat Oncol; 2021 Aug; 16(1):147. PubMed ID: 34372887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.